サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562193

北米のPCR技術：2030年までの市場予測 - 地域分析 - 技術、提供、用途、エンドユーザー別

North America PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology, Offerings, Application, and End User

出版日
ページ情報
英文 140 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
北米のPCR技術：2030年までの市場予測 - 地域分析 - 技術、提供、用途、エンドユーザー別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 140 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のPCR技術市場は、2022年の50億7,581万米ドルから2030年には96億3,486万米ドルに成長すると予測されています。2022年から2030年までのCAGRは8.3%を記録すると推定されます。

PCR技術の進歩が北米のPCR技術市場に拍車をかける

絶妙な感度、相対的な簡便さ、費用対効果などのPCRの利点は、過去数年間、その人気に多大な付加を与えてきました。PCR技術は大きく進化しており、その結果、多種多様なアプリケーションに対してより具体的なワークフローを提供できるようになった。PCR技術の使用は、分子診断をより簡単かつ迅速にする、いくつかの非従来型アプリケーションに探求されています。dPCRとRT-PCRの進歩は病気の診断、ウイルスやバクテリアの同定、法医学的捜査の補助に使われています。研究者たちは、いくつかのナノ材料を用いて検査時間の短縮を試みています。2023年3月、韓国科学技術院（KIST）の拡張知能安全システムセンター（Center for Augmented Safety System with Intelligence, Sensing）は、超高速PCR技術の開発を発表しました。この開発プロジェクトはDr. Sang Kyung Kim（所長）とDr. Seungwon Jungの研究チームが主導しました。超高速PCRは、光熱ナノ材料を利用することで、検査時間を従来の10分の1に短縮します。診断性能は既存の検査法に匹敵し、5分で終了します。2021年1月、ダナハー社は、カナダ保健省がセファイド社にXpert Xpress SARS-CoV-2/Flu/RSVの医療機器ライセンスを発行したと発表しました。2021年3月、PCR Biosystems社はIsoFast Bstポリメラーゼ試薬の発売を発表しました。この試薬はRNAとDNAの高感度、堅牢、迅速な増幅をサポートし、より迅速な検査手順を可能にします。2021年10月、サーモフィッシャーサイエンティフィック社は、高精度で一貫性のある遺伝子解析を実現するために設計された初の完全統合型dPCRシステムであるApplied Biosystem Quantstudio Absolute Q-Digital PCR Systemを発表しました。この製品は90分以内に調査結果が得られるとしています。2022年5月、バイオ・ラッド・ラボラトリーズ社は、CFX Duet Real-Time PCRシステムをCEマークを承認している特定の国に導入しました。このシステムはシングルプレックスおよびデュプレックスqPCRアッセイの研究開発をサポートすることを目的としています。2022年11月、PCR Biosystems社は新しいqPCR試薬ミックスClara Probe Mix、Clara Probe 1-Step Mix、Clara HRM Mixを発売しました。2022年11月、Cepheid社はXpert Xpress MVPマルチプレックスPCR検査を発売しました。この治療法は、細菌性膣症（BV）、トリコモナス症、外陰膣カンジダ症という3つの異なる疾患に関連する細菌のDNAを1つのサンプルから検出するのに役立ち、より正確な診断と正確な抗生物質治療レジメンを支援します。したがって、このような進歩は、今後数年間でPCR技術市場に新たな動向をもたらすと予想されます。

北米のPCR技術市場概要

北米のPCR技術市場は米国、カナダ、メキシコに区分されます。この地域の市場成長は、バイオ分析機器メーカーやPCR企業からの革新的な製品に対する需要の増加、主要な市場プレイヤーの存在、様々な学術研究機関で行われる広範な調査に起因します。加えて、品質向上とコスト削減のためにヘルスケア業務に医療機器を採用することがよく知られていることも、米国や他の北米諸国のPCR技術市場に利益をもたらしています。研究や治療におけるCRISPRやPCRのような遺伝子合成・編集ツールの受容と採用の急増は、迅速な定量、改変、観察を助けるアッセイを必要とします。液滴デジタルPCRのようなデジタルPCRの出現は、スクリーニングに新たな機会を提供し、優れた感度と容易な適応性を提供します。米国は先進的な調査手法への投資を奨励するため、公的機関や民間団体から多額の資金援助を求めています。例えば、遺伝子工学・バイオテクノロジー国際センターは、加盟国の共同研究を刺激することを目的としています。国際遺伝子工学バイオテクノロジーセンターは、共同研究プログラム（CRP）を通じて資金援助を受けており、このプログラムは、関連性と関心のある独創的な科学的問題に取り組むことを目的としています。PCR技術に依存するバイオテクノロジーの進歩は、人間の健康、動物福祉、食糧安全保障の向上に役立ちます。米国食品医薬品局（USFDA）はバイオテクノロジー製品の安全性確保に尽力しています。米国は様々な研究グループや組織に積極的に参加し、異なる地域内でPCRに基づく動向や最新の調査研究を交換するのに役立つ科学会議、ワークショップ、イベントを実施しています。したがって、この国の積極的な関与もPCR技術市場の成長を促進する要因の一つです。

北米のPCR技術市場の収益と2030年までの予測（金額）

北米のPCR技術市場セグメンテーション

北米のPCR技術市場は、技術、提供、用途、エンドユーザー、国にセグメント化されます。

技術に基づき、北米のPCR技術市場はリアルタイムPCR、コンベンショナルPCR、逆転写、デジタルPCR、マルチプレックスRTPCR、ホットスタートPCR、その他に区分されます。リアルタイムPCRセグメントは2022年に北米のPCR技術市場で最大のシェアを占めました。

提供の観点から、北米のPCR技術市場は試薬&消耗品、機器、ソフトウェア&サービスに分類されます。試薬＆消耗品セグメントは2022年に北米のPCR技術市場で最大のシェアを占めました。さらに、試薬＆消耗品セグメントは試薬、バイアルサイズ、その他の消耗品に分類されます。さらに、バイアルサイズは0.2ml～2ml、0.1ml～0.3ml、2ml～5ml、その他のバイアルに区分されます。さらに、機器セグメントはベンチトップPCRとポータブルサーモサイクラー/PCRに二分されます。

用途別では、北米のPCR技術市場は、遺伝子発現解析、遺伝子配列決定、ジェノタイピング、核酸合成、標準バリデーション、ポイントオブケア診断アプリケーション、環境アプリケーション、その他に区分されます。遺伝子発現解析セグメントは、2022年に北米のPCR技術市場で最大のシェアを占めました。

エンドユーザーに基づき、北米のPCR技術市場は病院&診断センター、製薬&バイオテクノロジー企業、学術機関&研究所、その他に分類されます。病院＆診断センターセグメントが2022年の北米のPCR技術市場で最大のシェアを占めました。

国別では、北米のPCR技術市場は米国、カナダ、メキシコに分類されています。米国は2022年に北米のPCR技術市場を独占しました。

Thermo Fisher Scientific Inc、Promega Corp、QIAGEN NV、bioMerieux SA、Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Becton Dickinson and Co、Atila Biosystems Inc、Takara Bio Inc、Standard Bio Tools Inc、Agilent Technologies Inc、Visby Medical Inc、Ellume Ltdは北米のPCR技術市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米のPCR技術市場- 主要産業力学

  • PCR技術市場：主要産業力学
  • 市場促進要因
    • 遺伝性疾患と感染症の有病率の上昇
    • PCR技術への投資と資金調達の急増
  • 市場抑制要因
    • PCRシステムの高コストと代替アッセイの利用可能性
  • 市場機会
    • POC検査の需要の増加
  • 今後の動向
    • PCR技術の進歩
  • 促進要因と抑制要因の影響

第5章 PCR技術市場：北米市場分析

  • PCR技術の市場収益、2020年～2030年

第6章 北米のPCR技術市場分析：技術別

  • リアルタイムPCR
  • コンベンショナルPCR
  • 逆転写PCR
  • デジタルPCR
  • マルチプレックスRT PCR
  • ホットスタートPCR
  • その他

第7章 北米のPCR技術市場分析：提供別

  • 市場収益シェア、2022年および2030年
  • 試薬・消耗品
  • 器具
  • ソフトウェアとサービス

第8章 北米のPCR技術市場分析：用途別

  • 市場収益シェア、2022年および2030年
  • 遺伝子発現解析
  • 遺伝子配列決定
  • ジェノタイピング
  • 核酸合成
  • 標準バリデーション
  • ポイントオブケア診断
  • 環境用途
  • その他

第9章 北米のPCR技術市場分析：エンドユーザー別

  • 市場収益シェア、2022年および2030年
  • 病院および診断センター
  • 学術機関および研究機関
  • 製薬・バイオテクノロジー企業
  • その他

第10章 北米のPCR技術市場：国別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ

第11章 PCR技術市場：業界情勢

  • PCR技術市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • QIAGEN NV
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Becton Dickinson and Co
  • Atila Biosystems Inc
  • Takara Bio Inc
  • Standard Biotools Inc
  • Agilent Technologies Inc
  • Visby Medical Inc
  • Ellume Ltd

第13章 付録

図表

List Of Tables

  • Table 1. PCR Technologies Market Segmentation
  • Table 2. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Technology
  • Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
  • Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
  • Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
  • Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
  • Table 9. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 10. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 11. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 12. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 13. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 14. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 15. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 16. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 17. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 18. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 19. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 20. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 21. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 22. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 23. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 24. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 25. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 26. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 27. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 28. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 29. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 30. Recent Inorganic Growth Strategies in the PCR Technologies Market
  • Table 31. Recent Organic Growth Strategies in the PCR Technologies Market
  • Table 32. Glossary of Terms, PCR Technologies Market

List Of Figures

  • Figure 1. PCR Technologies Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
  • Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
  • Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
  • Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
  • Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 30. North America: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. North America PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 32. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 33. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 34. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 35. Growth Strategies in the PCR Technologies Market
目次
Product Code: BMIRE00030517

The North America PCR technologies market is expected to grow from US$ 5,075.81 million in 2022 to US$ 9,634.86 million by 2030. It is estimated to record a CAGR of 8.3%from 2022 to 2030.

Advancements in PCR Technologies Fuel North America PCR Technologies Market

The advantages of PCR such as exquisite sensitivity, relative simplicity, and cost-effectiveness have tremendously added to its popularity in the past years. The PCR technology has evolved significantly, resulting in more specific workflows for a wide variety of applications. The use of PCR technology is being explored into several nonconventional applications, making molecular diagnosis easier and faster. Advancements in dPCR and RT-PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Researchers are trying to reduce test time using some nanomaterials. In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST) announced the development of an ultrafast PCR technology. The development project was led by Dr. Sang Kyung Kim (Director) and Dr. Seungwon Jung's research team. The ultrafast PCR reduces the test duration by 10 times compared to the previous tests by utilizing photothermal nanomaterials. The diagnostic performance of the new method is comparable to existing test methods, and it can be finished in 5 minutes. In January 2021, Danaher Corporation announced that Health Canada issued a medical device license to Cepheid for Xpert Xpress SARS-CoV-2/Flu/RSV. A few of the technological advancements by companies in the PCR technologies market are as given, In March 2021, PCR Biosystems announced the launch of its IsoFast Bst polymerase reagents, which support sensitive, robust, and rapid amplification of RNA and DNA, enabling faster testing procedures. In October 2021, Thermo Fisher Scientific introduced the Applied Biosystem Quantstudio Absolute Q-Digital PCR System, the first fully integrated dPCR system designed to deliver highly accurate and consistent genetic analysis. The company claims that the product generates research results within 90 minutes. In May 2022, Bio-Rad Laboratories, Inc. introduced its CFX Duet Real-Time PCR System in selected countries that accept the CE Mark. The system is intended to support researchers in developing singleplex and duplex qPCR assays. In November 2022, PCR Biosystems launched new qPCR reagent mixes-Clara Probe Mix, Clara Probe 1-Step Mix, and Clara HRM Mix. In November 2022, Cepheid launched the Xpert Xpress MVP multiplex PCR test. The test helps detect DNA from organisms that are associated with three distinct conditions, namely, bacterial vaginosis (BV), trichomoniasis, and vulvovaginal candidiasis, from a single sample, aiding in more precise diagnosis and supporting accurate antibiotic treatment regimens. Thus, such advancements are expected to bring new trends into the PCR technologies market in the coming years.

North America PCR Technologies Market Overview

The North America PCR technologies market is segmented into the US, Canada, and Mexico. Market growth in this region is attributed to the increased demand for innovative products from bioanalytical instrument manufacturers and PCR companies, the presence of key market players, and extensive R&D conducted across various academic and research institutes. In addition, the well-known practice of adopting medical devices in healthcare operations to improve quality and reduce costs also benefits the PCR technologies market in the US and other North American countries. An upsurge in the acceptance and adoption of gene synthesis and editing tools such as CRISPR and PCR in research and therapeutics necessitates assays that aid in rapid quantification, alterations, and observation. The emergence of digital PCR in the form of droplet digital PCR offers new opportunities for screening, providing superior sensitivity and easy adaptability. The US is seeking significant funding from public and private organizations to encourage investments in advanced research methodologies. For instance, the International Centre for Genetic Engineering and Biotechnology aims to stimulate collaborative research in the member states. It receives funds through the Collaborative Research Programme (CRP) that aims to address original scientific problems of relevance and interest. Advancements in biotechnology that depend on PCR techniques to help improve human health, animal welfare, and food security. The US Food and Drug Administration (USFDA) is committed to ensuring the safety of biotechnology products. The US actively participates in various research groups and organizations to conduct scientific conferences, workshops, and events that help exchange the trends and latest research studies based on PCR within different geographies. Therefore, the country's active involvement is also one of the factors driving the growth of the PCR technologies market.

North America PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

North America PCR Technologies Market Segmentation

The North America PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the North America PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of North America PCR technologies market in 2022.

In terms of offerings, the North America PCR technologies market is categorized into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of North America PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR and portable thermocyclers/PCR.

By application, the North America PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of North America PCR technologies market in 2022.

Based on end user, the North America PCR technologies market is categorized into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of North America PCR technologies market in 2022.

By country, the North America PCR technologies market has been categorized into the US, Canada, and Mexico. The US dominated the North America PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Atila Biosystems Inc, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, Visby Medical Inc, and Ellume Ltd are some of the leading companies operating in the North America PCR technologies market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America PCR Technologies Market - Key Industry Dynamics

  • 4.1 PCR Technologies Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.2.2 Surging Investments and Funds Availability for PCR Technologies
  • 4.3 Market Restraints
    • 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Demand for POC Testing
  • 4.5 Future Trends
    • 4.5.1 Advancements in PCR Technologies
  • 4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - North America Market Analysis

  • 5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. North America PCR Technologies Market Analysis - By Technology

  • 6.1 Overview
  • 6.2 Real Time PCR
    • 6.2.1 Overview
    • 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Conventional PCR
    • 6.3.1 Overview
    • 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Reverse Transcription PCR
    • 6.4.1 Overview
    • 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Digital PCR
    • 6.5.1 Overview
    • 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Multiplex RT PCR
    • 6.6.1 Overview
    • 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Hot Start PCR
    • 6.7.1 Overview
    • 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. North America PCR Technologies Market Analysis - By Offerings

  • 7.1 Overview
  • 7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
  • 7.3 Reagents and Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
        • 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • 7.5 Software and Services
    • 7.5.1 Overview
    • 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. North America PCR Technologies Market Analysis - By Application

  • 8.1 Overview
  • 8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Gene Expression Analysis
    • 8.3.1 Overview
    • 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Genetic Sequencing
    • 8.4.1 Overview
    • 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genotyping
    • 8.5.1 Overview
    • 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Nucleic Acid Synthesis
    • 8.6.1 Overview
    • 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Standard Validation
    • 8.7.1 Overview
    • 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Point of Care Diagnostics
    • 8.8.1 Overview
    • 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Environmental Application
    • 8.9.1 Overview
    • 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Others
    • 8.10.1 Overview
    • 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. North America PCR Technologies Market Analysis - By End User

  • 9.1 Overview
  • 9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Academia and Research Institutes
    • 9.4.1 Overview
    • 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pharmaceutical and Biotechnology Companies
    • 9.5.1 Overview
    • 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. North America PCR Technologies Market - Country Analysis

  • 10.1 North America: PCR Technologies Market
    • 10.1.1 Overview
    • 10.1.2 North America PCR Technologies Market Revenue and Forecast and Analysis - By Country
      • 10.1.2.1 United States
        • 10.1.2.1.1 Overview
      • 10.1.2.2 United States PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.1 United States PCR Technologies Market Breakdown by Technology
        • 10.1.2.2.2 United States PCR Technologies Market Breakdown by Offerings
        • 10.1.2.2.2.1 United States PCR Technologies Market Breakdown by Instruments
        • 10.1.2.2.2.2 United States PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.2.2.2.1 United States PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.2.3 United States PCR Technologies Market Breakdown by Application
        • 10.1.2.2.4 United States PCR Technologies Market Breakdown by End User
      • 10.1.2.3 Canada
        • 10.1.2.3.1 Overview
      • 10.1.2.4 Canada PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.1 Canada PCR Technologies Market Breakdown by Technology
        • 10.1.2.4.2 Canada PCR Technologies Market Breakdown by Offerings
        • 10.1.2.4.2.1 Canada PCR Technologies Market Breakdown by Instruments
        • 10.1.2.4.2.2 Canada PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.4.2.2.1 Canada PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.4.3 Canada PCR Technologies Market Breakdown by Application
        • 10.1.2.4.4 Canada PCR Technologies Market Breakdown by End User
      • 10.1.2.5 Mexico
        • 10.1.2.5.1 Overview
      • 10.1.2.6 Mexico PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.1 Mexico PCR Technologies Market Breakdown by Technology
        • 10.1.2.6.2 Mexico PCR Technologies Market Breakdown by Offerings
        • 10.1.2.6.2.1 Mexico PCR Technologies Market Breakdown by Instruments
        • 10.1.2.6.2.2 Mexico PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.6.2.2.1 Mexico PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.6.3 Mexico PCR Technologies Market Breakdown by Application
        • 10.1.2.6.4 Mexico PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the PCR Technologies Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 QIAGEN NV
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 bioMerieux SA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Hoffmann-La Roche Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Bio-Rad Laboratories Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Becton Dickinson and Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Atila Biosystems Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Takara Bio Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Standard Biotools Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Agilent Technologies Inc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Visby Medical Inc
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Ellume Ltd
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms